Congrès santé - Formation santé

3rd New Product Planning Summit

Réf: 27857 12/12/2018 -> 13/12/2018 - Boston ^US

The 3rd New Product Planning Summit will take place December 12-13 in Boston serving as a platform for early product development, launch management, brand planning and marketing executives to address the cross-functional challenges across a product’s development cycle. This event will feature ...

Tumor Targeted Lymphocyte Summit 2018 | Boston, MA | December 12-13, 2018

Réf: 27951 12/12/2018 -> 13/12/2018 - Boston ^US

The Tumor Targeted Lymphocyte Summit is the first, dedicated meeting that unites the expert community working in TIL and CTL therapies to network, learn and determine strategies to enhance the efficacy of this adoptive cell therapy in solid tumors. As CAR-T fails in the fight to deliver ...

How to be Efficient and Compliant with Part 11, Validation, and SaaS/Cloud

Réf: 28439 04/02/2019 -> 05/02/2019 - Boston ^US

This interactive two-day course explores proven techniques for reducing costs associated with implementing, using, and maintaining computer systems in regulated environments.

Immunometabolism Drug Development Summit

Réf: 28302 12/02/2019 -> 13/02/2019 - Boston ^US

As scientific breakthroughs and novel discoveries reveal the causal link and interface between metabolic pathways and immune cell function, the inaugural Immunometabolism Drug Development Summit 2019 is dedicated to help large pharma, biotech and academia translate basic immunometabolism research ...

7th World CNS 2019

Réf: 28220 19/02/2019 -> 21/02/2019 - Boston ^US

    Solving Translational Research Challenges to Improve Clinical Efficacy The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research. World CNS’s mission is to reinvigorate drug discovery and ...

ICO-IO Combinations Summit 2019

Réf: 28492 19/03/2019 -> 21/03/2019 - Boston ^US

Advancing ICI-containing IO-combination therapies is central to getting the full therapeutic benefit out of ICIs. Selecting the right combination partners and strategies are essential to the making the correct decision.   This industry-led meeting will focus on how the response rate to ...

3rd Annual Gene Therapy for Rare Disorders

Réf: 28513 26/03/2019 -> 28/03/2019 - Boston ^US

Gene Therapy for Rare Disorders is a uniquely focused conference that will unite the leaders in this field to identify and discuss the critical factors that will influence genetic treatments most significantly in the near future.
Bringing together leading experts from innovative biotechs, ...

2nd Antigen-Specific Immune Tolerance Summit 2019

Réf: 28563 26/03/2019 -> 28/03/2019 - Boston ^US

    As the race to generate compelling clinical data to prove the concept of antigen-specific immunotherapies gains momentum, the 2nd Antigen-Specific Immune Tolerance Drug Development Summit returns to Boston in 2019 to help large pharma, biotech, and academic researchers to ...

Pre-Filled Syringes East Coast

Réf: 28532 08/04/2019 -> 09/04/2019 - Boston ^US

SMi Group presents its 6th Annual Pre-Filled Syringes East Coast 2019 Conference and Exhibition taking place on the 8th, 9th April in Boston

SMi's 2nd Annual Conference Pharmaceutical Microbiology East Coast

Réf: 28449 10/04/2019 -> 11/04/2019 - Boston ^US

    SPONSORS: Associates of Cape Cod, Charles River, bioMerieux, and DuPont CHAIRMAN: James Drinkwater, Chairman, Pharmaceutical and Healthcare Sciences Society The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With ...

3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA

Réf: 28238 22/04/2019 -> 25/04/2019 - Boston ^US

Be at the forefront of the insights from 60+ leading experts as they share their learnings on: Commercialization challenges, the payers perspective and the investors’ criteria for business in the current and future NASH market The non-invasive diagnostics landscape and regulatory ...

International Cannabinoid Derived Pharmaceuticals Summit

Réf: 27826 10/12/2018 -> 12/12/2018 - Boston ^US

With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, ...